Dr. Farber is a graduate of Brown University and obtained his medical degree from Harvard Medical School. He completed a residency in general surgery at Massachusetts General Hospital; a vascular surgery fellowship at Dartmouth-Hitchcock Medical Center; and an endovascular surgery fellowship at the Southern Illinois School of Medicine. In addition to his role as Division Chief of Vascular and Endovascular Surgery, Dr. Farber is also Medical Director of BMC’s Catheterization and Angiography Laboratories and Co-Director of BMC’s Vascular Non-invasive Laboratory as well as Associate Chair for Clinical Operations in the Department of Surgery. He is a fellow in the American College of Surgeons and is a member of the American Board of Surgery. He is a member of many national and regional medical and surgical societies, including the Society for Vascular Surgery, where he was elected to distinguished fellow status in 2013, the Society of University Surgeons, the Western Vascular Surgery Society, the New England Society for Vascular Surgery, the International Society for Endovascular Surgery, and the Society for Clinical Vascular Surgery. Dr. Farber has served as a principal investigator in a number of clinical trials and is currently a National Co-Chair of the BEST-CLI Trial (Best Endovascular versus Best Surgical Therapy in Patients with Critical Limb Ischemia), a $25 million grant awarded by the National Institutes of Health (NIH), to conduct a four-year, randomized clinical trial comparing traditional bypass surgery with the less invasive alternative of endovascular treatment for patients with critical limb ischemia (CLI). He has written and published many articles about vascular and endovascular surgery, has served as a moderator for various vascular meetings, and developed a formal education program in vascular surgery while at Cedar-Sinai Medical Center in Los Angeles, CA, which resulted in the Golden Apple Teaching Award for teaching and mentoring residents. Since his arrival at BMC, Dr. Farber has made it his goal and mission to foster continued clinical excellence and academic productivity. He is currently the director of a fourth year medical school elective (BMC Surgery Bootcamp) which is designed to prepare medical students who are going into surgical internship.
- Professor, Vascular and Endovascular Surgery, Surgery, Boston University School of Medicine
- Section Chief, Vascular and Endovascular Surgery, Surgery, Boston University School of Medicine
- Member, Evans Center for Interdisciplinary Biomedical Research, Boston University
- Harvard Medical School, MD
- Brown University, BS
- Published on 6/11/2020
Cheng T, Boelitz K, Rybin D, Menard MT, Kalish J, Siracuse JJ, Farber A, Jones DW. Nationwide Patterns in Industry Payments to Academic Vascular Surgeons. J Vasc Surg. 2020 Jun 11. PMID: 32535153.
- Published on 6/3/2020
Levin SR, Farber A, Malas MB, Tan TW, Conley CM, Salavati S, Arinze N, Cheng TW, Rybin D, Siracuse JJ. Association of Anesthesia Type with Outcomes After Outpatient Brachiocephalic Arteriovenous Fistula Creation. Ann Vasc Surg. 2020 Jun 03. PMID: 32504791.
- Published on 6/3/2020
de Geus SWL, Farber A, Levin S, Carlson SJ, Cheng TW, Tseng JF, Siracuse JJ. Perioperative Outcomes of Carotid Interventions in Octogenarians. Ann Vasc Surg. 2020 Jun 03. PMID: 32504792.
- Published on 6/1/2020
Siracuse JJ, Farber A. Lower extremity vascular access creation is a marker for advanced end-stage renal disease. J Vasc Surg. 2020 Jun; 71(6):2185. PMID: 32446524.
- Published on 5/22/2020
Marston WA, Kirsner RS, Tallis A, Hanft JR, Walters J, Farber A. Economic benefit of a novel dual-mode ambulatory compression device for treatment of chronic venous leg ulcers in a randomized clinical trial. J Vasc Surg Venous Lymphat Disord. 2020 May 22. PMID: 32451241.
- Published on 5/20/2020
Levin SR, Farber A, Arinze N, Talutis SD, Cheng TW, Malas MB, Tan TW, Rybin D, Siracuse JJ. Intravenous Drug Use History Is Not Associated with Poorer Outcomes After Arteriovenous Access Creation. J Vasc Surg. 2020 May 20. PMID: 32445833.
- Published on 5/19/2020
Raulli SJ, Sather K, Dicken QG, Farber A, Kalish JA, Eslami MH, Zhang Y, Cheng TW, Levin SR, Siracuse JJ. Higher Body Mass Index is Associated with Reinterventions and Lower Maturation Rates after Upper Extremity Arteriovenous Access Creation. J Vasc Surg. 2020 May 19. PMID: 32442609.
- Published on 5/18/2020
Mendez L, Zhao Q, Elsadawi M, Farber A, Bowden A, Sharpe C, Schulze R, Siracuse JJ. A Cost Analysis of Pathology Evaluation of Carotid Plaque after Endarterectomy. Ann Vasc Surg. 2020 May 18. PMID: 32439530.
- Published on 5/13/2020
Paredes LG, Arinze NV, Farber A, Garofalo D, Cheng TW, Levin SR, Vilvendhan R, Siracuse JJ. Periprocedural Outcomes in Patients on Chronic Anticoagulation Undergoing Fistulograms. Ann Vasc Surg. 2020 May 13. PMID: 32416311.
- Published on 5/1/2020
Farber A. Clinical correlation of vein graft adaptation. J Vasc Surg. 2020 May; 71(5):1629. PMID: 32334728.
View 261 more publications: View full profile at BUMC